therapy

Patients With Advanced Kidney Cancer: Switching To Metronomic Therapy Could Offer New Treatment Option

An article published Online First in The Lancet Oncology reports that a new multi-targeted “chemo-switch” drug regimen shows promising anti-tumor activity with manageable side effects in patients with (RCC).

, , ,